Grifols (GRFS) EPS (Weighted Average and Diluted) (2010 - 2020)

Grifols (GRFS) reported EPS (Weighted Average and Diluted) of -$74918.8 for Q1 2020, down 5.28% on a YoY basis from -$79091.5 in Q2 2019, and up 66.32% quarter-over-quarter from -$222472.2 in Q4 2019.

Grifols (GRFS) EPS (Weighted Average and Diluted) (2010 - 2020) Analysis & Trends

Grifols has reported EPS (Weighted Average and Diluted) for 10 years, with the latest figure at -$74918.8 in Q1 2020.

  • For the quarter ending Q1 2020, EPS (Weighted Average and Diluted) fell 5.28% year-over-year to -$74918.8; the trailing twelve-month figure through Dec 2021 stood at $1.1 million (up 7.05% YoY), and the FY2025 full-year result was $0.69, up 179.43% from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2020 stood at -$74918.8, up from -$222472.2 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $688298.3 in Q3 2016, with the low at -$222472.2 in Q4 2019.
  • Historically, EPS (Weighted Average and Diluted) has averaged $98450.3 across 5 years, with a median of -$64670.1 in 2018.
  • Annual changes were most pronounced in 2016 — EPS (Weighted Average and Diluted) soared 13149259.48% — and 2017, when it plunged 119919.01%.
  • Grifols' EPS (Weighted Average and Diluted) stood at $688298.3 in 2016, then sank by 131.11% to -$214156.1 in 2017, then increased by 9.14% to -$194586.4 in 2018, then dropped by 14.33% to -$222472.2 in 2019, then surged by 66.32% to -$74918.8 in 2020.
  • The last three EPS (Weighted Average and Diluted) figures came in at -$74918.8 (Q1 2020), -$222472.2 (Q4 2019), and -$71164.3 (Q1 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 8.26
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 2.14
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 0.39
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -1.72
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 3.34
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.61
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 0.47
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 1.31
10 Grifols 6.05 Bn 5.09 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -74,918.82
Dec 31, 2019 -222,472.25
Mar 31, 2019 -71,164.33
Dec 31, 2018 -194,586.40
Jun 30, 2018 373,557.45
Mar 31, 2018 -66,299.00
Dec 31, 2017 -214,156.14
Jun 30, 2017 565,853.66
Mar 31, 2017 -63,041.19
Sep 30, 2016 688,298.31
Jun 30, 2016 460,279.49
Mar 31, 2016 52.61
Dec 31, 2015 173.30
Sep 30, 2015 237,464.41
Jun 30, 2015 3.50
Mar 31, 2015 57.51
Sep 30, 2013 106,629.11
Jun 30, 2013 169,996.30
Mar 31, 2013 337,044.44
Dec 31, 2012 152,374.67